Results 91 to 100 of about 476,790 (282)

Allocation of patients with liver cirrhosis and organ failure to intensive care:Systematic review and a proposal for clinical practice [PDF]

open access: yes, 2015
AIM: To propose an allocation system of patients with liver cirrhosis to intensive care unit (ICU), and developed a decision tool for clinical practice. METHODS: A systematic review of the literature was performed in PubMed, MEDLINE and EMBASE databases.
Furhmann, Valentin   +6 more
core   +2 more sources

Applicability of the Chronic Liver Failure-Consortium score in patients with cirrhosis and bacterial infections: a single-clinic experience

open access: yesGastroenterologìa, 2021
Background. The frequency and characteristics of acute-on-chronic liver failure (ACLF) are reported in numerous articles from different countries. The aim of the study was to assess the cirrhosis decompensation in patients with bacterial infections based
D.I. Haurylenka, N.N. Silivontchik
doaj   +1 more source

Bacterial Infections in End-Stage Liver Disease: Implications for Liver Transplantation

open access: yesTransplantology
Bacterial infections are a common complication in patients with decompensated liver cirrhosis. The complex landscape of cirrhosis, characterized by immune paralysis and an exhausted response to exogenous triggers, explains the higher prevalence of such ...
Alberto Ferrarese   +13 more
doaj   +1 more source

Survival after liver transplantation in the United Kingdom and Ireland compared with the United States

open access: yes, 2007
<b>Background and Aim</b>: Surgical mortality in the US is widely perceived to be superior to that in the UK. However, previous comparisons of surgical outcome in the two countries have often failed to take sufficient account of case-mix or ...
Copley, L.P.   +4 more
core   +2 more sources

Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection. [PDF]

open access: yes, 2017
Consistent with Dr. Paul Terasaki's "humoral theory of rejection" numerous studies have shown that HLA antibodies can cause acute and chronic antibody mediated rejection (AMR) and decreased graft survival. New evidence also supports a role for antibodies
Butler, Carrie L   +3 more
core   +4 more sources

Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver disease

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: In patients with acute and chronic liver disease, von Willebrand factor (VWF) antigen levels are markedly elevated, whereas a disintegrin and metalloproteinase with thrombospondin type 1 motifs, member 13 (ADAMTS13) activity is often reduced.
Hinde El Otmani   +6 more
doaj   +1 more source

Clinical Characteristics and Outcome of Acute on Chronic Liver Failure Patients at Fatmawati General Hospital

open access: yesThe Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2020
Background: Acute-on-chronic liver failure (ACLF) is a syndrome characterized by acute liver decompensation with extrahepatic organ failure in patients with pre-existing liver disease causing high short-term mortality.
Nikko Darnindro   +6 more
doaj   +1 more source

Clinical intestinal transplantation: New perspectives and immunologic considerations [PDF]

open access: yes, 1998
Background: Although tacrolimus-based immunosuppression has made intestinal transplantation feasible, the risk of the requisite chronic high- dose treatment has inhibited the widespread use of these procedures.
Abu-Elmagd, K   +14 more
core   +1 more source

IMPACT OF SARCOPENIA ON THE PROGNOSIS OF PATIENTS WITH CIRRHOSIS HOSPITALIZED FOR ACUTE DECOMPENSATION OR ACUTE-ON-CHRONIC LIVER FAILURE [PDF]

open access: yesArquivos de Gastroenterologia
Background: Cirrhosis is a prevalent disease and ranks among the leading causes of death worldwide. Sarcopenia is believed to be associated with a poorer prognosis in patients with cirrhosis.
Leticia Macedo EIFLER   +5 more
doaj   +1 more source

Changing perspectives on liver transplantation in 1988. [PDF]

open access: yes, 1988
After liver transplantation for cancer, there is a high incidence of disease recurrence within 18 to 36 months for most tumors, although there are a small number of long-term survivors.
Gordon, RD, Starzl, TE
core  

Home - About - Disclaimer - Privacy